Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each…
The Fight Fentanyl Act amends the Office of National Drug Control Policy Act to increase HIDTA funding, require new fentanyl-focused HIDTA reporting, expand HIDTA purposes to support interdiction, and mandate temporary reassignment of Assistant U.S. Attorneys to prioritize fentanyl prosecutions.
It authorizes $333,000,000 annually for HIDTA for fiscal years 2025–2030, raises a related program amount (to $14,224,000), and directs the Attorney General to create a process for requesting temporarily reassigned prosecutors within 180 days of enactment.
Moderately likely because of broad support for fentanyl enforcement, but passage depends on appropriations and competing fiscal priorities.
Relative to its intended legislative type, this bill is a substantive statutory amendment focused on enhancing HIDTA and DOJ activity against fentanyl; it integrates cleanly into existing statutory sections and supplies concrete funding authorizations and some process requirements, but leaves several operational, fiscal, and oversight details under-specified.
Progressive criticizes emphasis on enforcement over treatment
Progressive criticizes emphasis on enforcement over treatment
Likely cautiously supportive of efforts to reduce fentanyl harm but concerned the bill focuses heavily on law enforcement rather than public health.
Will note the bill expands funding and prosecution priorities, but highlights missing investment in treatment, harm reduction, and racial equity safeguards.
Generally favorable to clearer funding and coordination against fentanyl, while seeking accountability and measurable outcomes.
Will appreciate concrete dollar amounts and DOJ role but want oversight, cost justification, and proof interdiction reduces overdoses.
Likely supportive because the bill increases enforcement resources and prioritizes prosecution of fentanyl traffickers.
Views strengthened HIDTA capabilities and reassigned federal prosecutors as effective tools to disrupt supply networks.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderately likely because of broad support for fentanyl enforcement, but passage depends on appropriations and competing fiscal priorities.
The bill has not accumulated any surfaced votes yet.
Progressive criticizes emphasis on enforcement over treatment
Moderately likely because of broad support for fentanyl enforcement, but passage depends on appropriations and competing fiscal priorities.
Relative to its intended legislative type, this bill is a substantive statutory amendment focused on enhancing HIDTA and DOJ activity against fentanyl; it integrates cleanly into existing statutory sections and supplies…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.